![Steven Vroegop](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven Vroegop
Corporate Officer/Principal en Michigan High Throughput Screening Center .
Cargos activos de Steven Vroegop
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Michigan High Throughput Screening Center
![]() Michigan High Throughput Screening Center Miscellaneous Commercial ServicesCommercial Services Michigan High Throughput Screening Center develops screening technologies for drug discovery. It offers services to academic institutions, biotechnology & pharmaceutical companies, and government laboratories. The firm is a not-for-profit contract research organization. Its scientists has extensive experience in drug discovery research and have experience in developing, validating and implementing high throughput screening assays for a broad range of drug targets in central nervous system disease, inflammation, infectious diseases, and oncology. It also has an extremely diverse library containing 100,000 drug able compounds and requires no licensing fees or royalties. | Corporate Officer/Principal | - | - |
Director Técnico/Científico/I+D | 30/04/2010 | 30/04/2010 |
Historial de carrera de Steven Vroegop
Estadísticas
Internacional
Estados Unidos | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Michigan High Throughput Screening Center
![]() Michigan High Throughput Screening Center Miscellaneous Commercial ServicesCommercial Services Michigan High Throughput Screening Center develops screening technologies for drug discovery. It offers services to academic institutions, biotechnology & pharmaceutical companies, and government laboratories. The firm is a not-for-profit contract research organization. Its scientists has extensive experience in drug discovery research and have experience in developing, validating and implementing high throughput screening assays for a broad range of drug targets in central nervous system disease, inflammation, infectious diseases, and oncology. It also has an extremely diverse library containing 100,000 drug able compounds and requires no licensing fees or royalties. | Commercial Services |
- Bolsa de valores
- Insiders
- Steven Vroegop
- Experiencia